For cervical cancer awareness month, Lauren Bollinger, MD, discusses how the increase in research in the field of cervical cancer is driving the progress of treatment....
The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
American researchers are finding their new findings on periodontal disease journal Intestine Titled “Periodontal Disease, Tooth Loss, and Risk of Esophageal and Gastric Adenocarcinoma: A Prospective...
Recent Comments